Putting data to work in the face of vaccine hesitancy

Register to view video
By Dr. Glen Nowak, Memi Miscally , and Dr. John Boyle, PhD

More than a dozen pharmaceutical companies are working to deploy a safe and effective vaccine against COVID-19. But how could perceptions and attitudes impact immunization efforts, and what can agencies do to build trust and participation?

Join ICF's survey research and communications experts along with Glen Nowak, director of the Grady College’s Center for Health and Risk Communication at the University of Georgia and former communications director for CDC’s National Immunization Program, as we discuss:

  • How attitudes towards immunization against COVID-19 have been trending over time, and what factors influence Americans’ perceptions. 
  • How to evaluate data in changing circumstances and understand how to address diverse communities.
  • How to put data assessment to work in designing and implementing effective communications.

Glen Nowak, Director of Center for Health & Risk Communications, Professor, Advertising- University of Georgia
Memi Miscally- Partner, Research & Evaluation, ICF Next 
John Boyle, Ph.D.- Senior Survey Advisor, ICF

Go to ICF
Meet the authors
  1. Dr. Glen Nowak, Director of Center for Health & Risk Communication, University of Georgia
  2. Memi Miscally , Director of Social Marketing Research, ICF Next
  3. Dr. John Boyle, PhD , Senior Survey Advisor, ICF